AI & Emerging Technology

The junior explorer is terminating its NWA project option to double down on promising uranium anomalies in Wyoming and a major conductive corridor in Athabasca.

A key advisory appointment reveals a pivotal trend in private equity: a move from deal-making to deep operational focus for maximizing portfolio returns.

A new patent for its lead cancer drug in Japan is more than a legal win; it's a strategic move to secure a future market into the 2040s.

Protara Therapeutics secured a $75M offering to advance its promising cancer drug, TARA-002, signaling renewed investor confidence in biotech innovation.

A breakthrough therapy using the gut microbiome shows a 54% survival rate for a fatal transplant complication, heralding a new era in oncology treatment.

Sensorion clears a key safety hurdle for its infant hearing loss gene therapy, but early data reveals a tight race to market against formidable rivals.

Promising long-term data and key regulatory wins position Wugen's allogeneic therapy to disrupt the challenging T-cell cancer treatment landscape.

A new partnership seeks to launch a 50-branch roofing giant in one year, betting on a single software platform to conquer a fragmented, low-tech industry.

New polling reveals Gen Z's surprising conservative turn, driven not by ideology but a deep revolt against a system they believe has failed them.

As REV Group preps its Q4 report, all eyes are on whether its booming specialty vehicle segment can offset volatility in the recreational vehicle market.

Andersen Consulting partners with Romanian software firm Codezilla. We decode the strategy, the nearshoring trend, and what it means for the competition.

A new partnership aims to bring the HBCU experience to millions online, but can it preserve the culture that makes these institutions so vital?